Document is current
Any future updates will be listed below
-
Authors
Sharma, Vandana
Pichon, Marjorie
Tewolde, Samuel
Solomon, Arsema
Deyessa, Negussie
Leight, Jessica
-
Funding
Funding for this research was provided by:
Fondation de France
Anonymous donor
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 25 November 2025
First Online: 2 March 2026
Declarations
:
: The protocol for the evaluation (including the qualitative data collection) was reviewed and approved by the Committee on the Use of Humans as Experimental Subjects at MIT (protocol number 1211005333) and by the Institutional Review Board at the AAU College of Health Sciences (protocol number 044/12/SPH). In addition, the trial was prospectively registered on clinicaltrials.gov (NCT02311699; 02/12/2014), and at the American Economic Association registry (AEARCTR-0000211). Finally, a community advisory board including a principal investigator, representatives from study districts and other key stakeholders (including government officials) was convened regularly for supervision and adverse event monitoring. All participants provided verbal informed consent. This study was carried out in accordance with relevant ethical guidelines and regulations including the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.
